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Wakayama, JapanObjectives The aim of the study was to investigate whether intravascular ultrasound (IVUS) can
predict microvascular obstruction (MVO) as detected by magnetic resonance imaging (MRI) after
primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial
infarction (STEMI).
Background MVO occurs in a sizable proportion of patients with acute myocardial infarction despite
successful PCI and results in poor clinical outcomes.
Methods We assessed infarct-related lesions in 68 patients with STEMI by using IVUS before primary
PCI. All patients were examined by MRI 1 week after primary PCI.
Results MRI-derived MVO was seen in 23 patients (34%). In the IVUS assessment, the frequency of
plaque rupture, echolucent plaque, calciﬁcation and positive remodeling, and quantitative geometric
data were not different between the MVO group and the no-MVO group. Although the frequency of
plaque with ultrasound attenuation was similar between the 2 groups (87% vs. 89%, p ¼ 0.999), the
maximum attenuation angle (280 [range: 215 to 360] vs. 150 [range: 95 to 300], p ¼ 0.008) and
attenuation length (11.3 mm [range: 7.2 to 17.8 mm] vs. 6.8 mm [range: 3.0 to 10.4 mm], p ¼ 0.009)
were signiﬁcantly greater in the MVO group than the no-MVO group. Multivariable logistic regression
analysis showed that attenuated plaque with a maximum attenuation angle of >180 and attenuation
length of >5 mm was an independent predictor of MVO (odds ratio: 6.07, 95% conﬁdence interval:
1.89 to 19.53, p ¼ 0.002).
Conclusions Attenuated plaque with maximum attenuation angle of >180 and attenuation length
of >5 mm was associated with the occurrence of MVO after primary PCI. IVUS might to be a useful tool
for risk stratiﬁcation in STEMI patients undergoing primary PCI. (J Am Coll Cardiol Intv 2013;6:847–53)
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848Percutaneous coronary intervention (PCI) is an established
reperfusion therapy for acutemyocardial infraction (AMI) (1).
Previous studies demonstrated that successful reopening of an
occluded epicardial coronary artery does not necessarily lead to
myocardial salvage. In fact, some AMI patients demonstrate
the “no-reﬂow” phenomenon, which refers to the absence of
myocardial perfusion due to microvascular obstruction
(MVO) even after successful reopening of the infarct-related
artery (2). MVO correlates with poorer global left ventricular
(LV) function and more frequent post-AMI complications
(3). Recently, contrast-enhancedmagnetic resonance imaging
(MRI) was introduced as the favored method to assess infarct
size and MVO (4,5). However, the predictor of MVO after
primary PCI has not yet been fully investigated.
Intravascular ultrasound (IVUS) is a useful tool to evaluate
coronary lesion characteristics. Resent IVUS studies showedAbbreviations
and Acronyms
AMI = acute myocardial
infarction
CK-MB = creatine kinase-
myocardial band
EEM = external elastic
membrane
IVUS = intravascular
ultrasound
LV = left ventricular
MRI = magnetic resonance
imaging
MVO = microvascular
obstruction
PCI = percutaneous coronary
intervention
STEMI = ST-segment
elevation myocardial
infarction
TIMI = Thrombolysis In
Myocardial Infarctionthat attenuated plaque (hypo-
echoic or mixed atheroma with
ultrasound attenuation but with-
out calciﬁcation) is associated
with a high rate of transient
deterioration in coronary ﬂow
during primary PCI and a larger
infarct size (6,7). These results
suggest that greater plaque
embolism might occur during
primary PCI in patients with
IVUS-detected attenuated pla-
que. The aim of the present study
was to investigate the association
between IVUS-detected attenu-
ated plaque and MRI-derived
MVO after primary PCI.
Methods
Study population. Between Sep-
tember 2010 andAugust 2011, weenrolled 68 patients with ST-segment elevation myocardial
infarction (STEMI) who underwent IVUS and were
successfully recanalized with PCI. During this time period,
PCI was performed in 96 STEMI patients in whom IVUS
guidance was used in 75%. We excluded patients with side
branch (>1 mm) occlusion after PCI, cardiogenic shock,
previous myocardial infarction, previous coronary bypass
surgery and renal insufﬁciency (serum creatinine>1.5mg/dl),
and patients in whom adequate IVUS images were not
obtained. A diagnosis of STEMI required the presence of
chest symptoms continuing for >30 min, ST-segment
elevation of >0.1 mV in 2 limb leads or >0.2 mV in
2 contiguous precordial leads on electrocardiogram, and an
increase in serum creatine kinase-myocardial band (CK-MB)
levels to more than twice the upper limit of normal. Clinical
data included risk factors, Killip class, time to reperfusion,and peak CK-MB level. This study was approved by the
Wakayama Medical University Ethics Committee, and all
patients provided informed consent before participation.
IVUS imaging and primary PCI. Oral aspirin (200 mg) and
intravenous heparin (100 U/kg) were administered before
coronary catheterization. Thrombolysis was not performed
for any patient. Coronary angiograms were obtained from
a standard series of 6 to 8 projections for the left coronary
artery and 2 to 3 projections for the right coronary artery. All
images were stored on a CD-ROM for ofﬂine analysis. The
infarct-related lesion was identiﬁed on the basis of the ﬁnd-
ings by a coronary angiogram as well as an electrocardiogram
and transthoracic echocardiogram. In patients with Throm-
bolysis In Myocardial Infarction (TIMI) ﬂow grade <2,
aspiration thrombectomy was performed using a 5.1-French
aspiration catheter (ExportCatheter, Medtronic Japan,
Tokyo, Japan), but pre-dilation by balloon catheter was not
allowed before IVUS imaging. IVUS imaging was performed
using a commercial scanner (Atlantis SR Pro, Boston
Scientiﬁc, Maple Grove, Minnesota) that consisted of a
40-MHz transducer. The IVUS catheter was advanced
beyond the infarct-related lesion and withdrawn to the aorto-
ostial junction at a pullback speed of 0.5 mm/s automatically.
The IVUS images were recorded on a DVD for ofﬂine
analysis. After IVUS imaging, PCI was performed using a 6-
French guiding catheter, a 0.014-inch guidewire, a monorail
balloon catheter, and a coronary stent with a conventional
technique. Decision making related to the PCI strategy was
left to the discretion of the individual PCI cardiologist. All
patients received dual antiplatelet therapy with aspirin (81
mg/day) and clopidogrel (75 mg/day) after primary PCI.
Angiographic analysis. Coronary angiograms were reviewed
by independent observers blinded to MRI ﬁndings. Quan-
titative angiographic analysis was performed by standard
techniques with automated edge-detection algorithm
(CASS-5, Pie Medical, Maastricht, the Netherlands). The
reference vessel diameter, minimal luminal diameter, and
percentage of diameter stenosis were measured in the culprit
lesion. Intracoronary thrombus was identiﬁed by angio-
graphic haziness, globular ﬁlling defect, or total occlusion
(8). The degree of perfusion was evaluated according to
TIMI criteria (9). Collaterals were graded according to
Rentrop’s classiﬁcation, with good collateral ﬂow deﬁned as
grade 2 or 3 (10). No-reﬂow phenomenon was deﬁned as
TIMI ﬂow grade 0, 1, or 2 without a mechanical obstruction
on angiograms after PCI. TIMI blush grade was also applied
to evaluate myocardial perfusion after PCI (11).
IVUS analysis. The IVUS images were analyzed by inde-
pendent observers blinded to MRI ﬁndings using a vali-
dated software (EchoPlaque, INDEC Systems, Inc.,
Mountain View, California). Qualitative analysis included
1. ultrasound attenuation behind the plaque in the absence
of calciﬁcation (6,7); 2. plaque rupture (the presence of
a cavity that communicated with the lumen with an
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849overlying residual ﬁbrous cap fragment); 3. intraplaque
echolucent zone (absence of ultrasound signal within the
plaque) (12); and 4. calciﬁcation (brighter plaque than
adventitia with an arc of >90 of acoustic shadowing).
Quantitative analysis was performed according to the
American College of Cardiology Clinical Expert Consensus
Document on Standards for Acquisition, Measurement,
and Reporting of Intravascular Ultrasound Studies (13).
The minimum lumen area site was determined by visual
screening for all contiguous frames. Cross-sectional areas of
external elastic membrane (EEM), lumen, and plaque and
media (plaque and media ¼ EEM  lumen) and plaque
burden (plaque and media divided by EEM) were measured
at the minimum lumen area site. The remodeling index was
calculated as the lesion EEM divided by the mean reference
EEM. Positive remodeling was deﬁned as a remodeling
index >1.05. In the plaque with ultrasound attenuation, the
maximum angle of the attenuation was measured. The
length of attenuation was calculated from the number of
seconds in which attenuation was identiﬁed (millimeters ¼
seconds of visible attenuation  0.5 mm/s). Referring to
previous IVUS studies (14,15), attenuated plaque was
deﬁned as a maximum attenuation angle >180 and atten-
uation length >5 mm in the present study.
MRI and analysis. Cardiac MRI was scheduled at 1 week
after PCI to assess MVO, LV function, and infarct size.
All patients were examined at rest in the supine position
with a whole-body 1.5-T MRI scanner (Intera Achieva,
Philips Medical Systems, Best, the Netherlands) equipped
with a 5-element cardiac phased-array coil for signal
reception. All images were obtained with electrocardio-
graphic gating in contiguous short-axis slices and repre-
sentative long-axis slices of the left ventricle during
repeated breath-holds.
Contrast-enhanced MRI was performed 10 min after
intravenous injection of 0.1 mmol/kg gadolinium dieth-
ylenetriamine pentaacetic acid. We optimized the inversion
time (200 to 300 ms) to nullify healthy myocardium. All
analyses were performed by independent observers blinded
to IVUS ﬁndings using an ofﬂine workstation (View Forum,
Philips, Berlin, Germany). LV ejection fraction, end-dia-
stolic volume, and end-systolic volume were calculated from
cine cardiac MRI. Infarct size was deﬁned as an area of
hyperenhancement on delayed enhanced images and calcu-
lated by automatic summation of all slice volumes of delayed
enhanced regions and expressed as a percentage of LV
volume (16). MVO was identiﬁed on delayed enhanced
images as a late hypoenhancement signal within the myo-
cardial wall surrounded by a hyperenhanced region and was
included in the calculation of total infarct size (17). A
representative case with MVO is shown in Figure 1.
Statistical analysis. Statistical analyses were performed
with SPSS version 11.0 (SPSS Inc., Chicago, Illinois).
Categorical variables were presented as frequency counts andpercentages, with comparison with chi-square statistics or
the Fisher exact test (if the expected cell value was <5).
Continuous variables were presented as median and inter-
quartile range and compared using the Mann-Whitney
U test. A multivariable logistic regression model was used to
determine predictors of MVO. The model included clinical,
angiographic, and procedural characteristics and quantitative
and qualitative IVUS ﬁndings with p < 0.20 in the
univariate analyses. A p value <0.05 was considered statis-
tically signiﬁcant.
Results
Patient clinical characteristics. Adequate MRI was obtained
in all patients. MRI-derived MVO was seen in 23 patients
(34%). Baseline clinical characteristics were not different
between the MVO group and the no-MVO group, except
for the peak CK-MB level after PCI, as summarized in
Table 1.
Angiographic ﬁndings and procedural characteristics. Angio-
graphic ﬁndings and procedural characteristics are shown in
Table 2. The distribution of the infarct-related artery was not
different between the MVO group and the no-MVO group.
Before PCI, the minimum lumen diameter in the infarct-
related arteries, presence of thrombus, and frequency of TIMI
ﬂow grade 0/1/2 and collateral ﬂow grade 2/3 were similar
between the 2 groups. After PCI, diameter stenosis, presence
of thrombus, and frequency of no reﬂow were not different
between the 2 groups. The frequency of post-PCI myocardial
blush grade 0/1 was signiﬁcantly higher in the MVO group
compared with the no-MVO group. There were no signiﬁ-
cant differences in procedural characteristics, stent proﬁles,
and time to reperfusion between the 2 groups.
IVUS ﬁndings. Pre-PCI IVUS ﬁndings in the infarct-related
lesions are summarized in Table 3. The frequency of plaque
rupture, echolucent plaque, calciﬁcation, and positive re-
modeling were not different between the MVO group and
the no-MVO group. Although the frequency of ultrasound
attenuation (87% vs. 89%, p ¼ 0.999) was similar between
the 2 groups, the maximum attenuation angle (280 [range:
215 to 360] vs. 150 [range: 95 to 300], p ¼ 0.008) and
attenuation length (11.3 mm [range: 7.2 to 17.8] vs. 6.8 mm
[range: 3.0 to 10.4], p ¼ 0.009) was signiﬁcantly greater in
the MVO group than the no-MVO group. Attenuated
plaque with an attenuation angle >180 and attenuation
length >5 mm was more frequently observed in the MVO
group compared than the no-MVO group (78% vs. 38%,
p ¼ 0.002). There was no difference in quantitative
geometric data of the infarct-related lesion between the
2 groups.
MRI ﬁndings. MRI ﬁndings at 1 week after PCI are shown
in Table 4. Although there was no difference in LV ejection
fraction, end-diastolic volume, and end-systolic volume be-
tween the 2 groups, infarct size was signiﬁcantly greater in
Figure 1. Representative Case of Intravascular Ultrasound–Detected Attenuated Plaque and Magnetic Resonance–Derived Microvascular Obstruction
(A) Angiography before percutaneous coronary intervention (PCI) demonstrated a subtotal occlusion in the mid right coronary artery (arrow). (B) An infarct-related
lesion was successfully recanalized by PCI without angiographic no-reﬂow phenomenon and distal embolization. (C, D) Cross-sectional and longitudinal intravascular
ultrasound images in the infarct-related lesion after aspiration thrombectomy showed attenuated plaque with a maximum attenuation angle of 225and an atten-
uation length of 20 mm. (E, F) Axial and sagittal views of contrast-enhanced magnetic resonance imaging at 1 week after primary PCI demonstrated microvascular
obstruction in the inferior wall of the left ventricle (arrows).
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850the MVO group compared with the no-MVO group (20.0%
[range: 13.0 to 25.0] vs. 13.5% [range: 7.5 to 20.0],
p ¼ 0.039).
Multivariable logistic regression model for MVO. Attenuated
plaque with an attenuation angle >180 and attenuation
length >5 mm was an independent predictor of MVO
(odds ratio: 6.07, 95% conﬁdence interval: 1.89 to 19.53,
p ¼ 0.002). Age, current smoker, pre-PCI quantitative
angiographic analysis data, and plaque rupture identiﬁed
by IVUS did not correlate with MVO in this model.
Prediction of the occurrence of MVO. The positive predic-
tive value and negative predictive value of the presence of
attenuated plaque for the incidence of MVO were 51% and
85%, respectively.Discussion
The major ﬁnding in this study was that IVUS-detected
attenuated plaque with a maximum attenuation angle >180
and an attenuation length >5 mm were associated with the
occurrence of MVO after primary PCI in STEMI patients.
To the best of our knowledge, this is the ﬁrst description of
the relationship between IVUS-detected attenuated plaque
and MRI-derived MVO.
MVO occurs in a sizable proportion of AMI patients
despite successful epicardial recanalization of the infarct-
related artery (3,18). Cardiac MRI directly visualizes and
sensitively detects MVO (19). Previous studies demonstrated
that MVO detected by cardiac MRI is correlated with
Table 3. Intravascular Ultrasound Findings
MVO Group
(n ¼ 23)
No-MVO Group
(n ¼ 45) p Value
Plaque rupture 15 (65) 20 (44) 0.105
Echolucent plaque 6 (26) 11 (24) 0.999
Calciﬁcation 22 (96) 38 (84) 0.250
Attenuation 20 (87) 40 (89) 0.999
Maximum attenuation angle,  280 (215–360) 150 (95–300) 0.008
Attenuation length, mm 11.3 (7.2–17.8) 6.8 (3.0–10.4) 0.009
Attenuated plaque 18 (78) 17 (38) 0.002
Measurement at MLA site
MLA, mm2 2.0 (1.9–2.4) 2.0 (1.8–2.4) 0.843
EEM area, mm2 17.5 (12.2–24.3) 16.5 (12.6–20.3) 0.361
P&M area, mm2 15.5 (10.7–21.2) 14.4 (10.5–17.7) 0.354
Plaque burden, % 89 (84–91) 87 (83–90) 0.547
Positive remodeling, % 18 (78) 32 (71) 0.527
Remodeling index 1.16 (1.05–1.24) 1.13 (0.98–1.28) 0.821
Values are n (%) or median (interquartile range).
EEM ¼ external elastic membrane; MLA ¼ minimum lumen area; MVO ¼ microvascular
obstruction; P&M ¼ plaque and media.
Table 1. Patient Clinical Characteristics
MVO Group
(n ¼ 23)
No-MVO Group
(n ¼ 45) p Value
Age, yrs 64 (54–73) 69 (60–77) 0.196
Male 16 (70) 33 (73) 0.743
Hypertension 16 (70) 30 (67) 0.809
Diabetes mellitus 10 (44) 15 (33) 0.412
Dyslipidemia 11 (48) 23 (51) 0.798
Current smoker 11 (48) 30 (67) 0.133
Killip class 2 2 (9) 5 (11) 0.999
Peak CK-MB, mg/dl 392 (228–485) 167 (74–296) <0.001
Values are median (interquartile range) or n (%).
CK-MB ¼ creatine kinase myocardial band; MVO ¼ microvascular obstruction.
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851histopathological evidence of severely disturbed microvascu-
lature (16,20). The mechanism and pathophysiology of
MVO are multifactorial, including microvascular spasm,
endothelial swelling, and capillary compression by edema
within the adjacent myocardial tissue. In addition, distalTable 2. Angiographic Findings and Procedural Characteristics
MVO Group
(n ¼ 23)
No-MVO Group
(n ¼ 45) p Value
Infarct-related artery 0.875
LAD 9 (39) 16 (36)
LCX 3 (13) 8 (18)
RCA 11 (48) 21 (47)
Pre-PCI
RVD, mm 3.6 (3.2–3.9) 3.2 (3.0–3.6) 0.094
MLD, mm 0.0 (0.0–0.2) 0.0 (0.0–0.4) 0.130
DS, % 100 (96–100) 100 (89–100) 0.124
Thrombus 21 (91) 43 (96) 0.599
TIMI ﬂow grade 0/1/2 22 (96) 43 (96) 0.999
Collateral ﬂow grade 2/3 2 (9) 5 (11) 0.999
Post-PCI
DS, % 8.0 (4.8–10.0) 6.0 (3.0–9.0) 0.360
Thrombus 3 (13) 5 (11) 0.999
No reﬂow 7 (30) 6 (13) 0.111
Myocardial blush grade
0/1
7 (30) 2 (4) 0.005
Procedure
Aspiration thrombectomy 21 (91) 42 (93) 0.999
No. of stents per patient 1.0 (1.0–1.0) 1.0 (1.0–1.0) 0.588
Stent diameter, mm 3.5 (3.0–4.0) 3.5 (3.0–3.5) 0.201
Stent-to-artery ratio 0.98 (0.82–1.06) 0.99 (0.88–1.09) 0.641
Stent length, mm 18.0 (16.0–20.0) 18.0 (12.0–18.0) 0.771
Maximum inﬂation
pressure, atm
16.0 (12.0–18.0) 16.0 (12.0–18.0) 0.937
Time to reperfusion, h 3.5 (2.6–4.7) 3.8 (3.1–6.0) 0.220
Values are n (%) or median (interquartile range).
DS ¼ diameter stenosis; LAD ¼ left anterior descending coronary artery; LCX ¼ left
circumﬂex coronary artery; MLD ¼ minimum lumen diameter; MVO ¼ microvascular obstruc-
tion; PCI ¼ percutaneous coronary intervention; RCA ¼ right coronary artery; RVD ¼ reference
vessel diameter; TIMI ¼ Thrombolysis In Myocardial Infarction.embolization of thrombi and plaque components liberated by
mechanical intervention is a major cause of MVO (21).
Therefore, identiﬁcation of coronary artery lesions that are
predisposed to causing distal embolization before primary
PCI might allow us to predict the occurrence of MVO.
IVUS-detected attenuated plaque is common in acute
coronary syndromes (ACS) and recognized as representing
vulnerable atherosclerotic lesions. In human cadaver coro-
nary arteries, attenuated plaque had a greater percentage of
necrotic core area than nonattenuated plaque (22). In a
multidetector computed tomography study, IVUS-detected
attenuated plaque presented typical low density of lipid-
rich tissue (<30 Hounsﬁeld units) (23). A virtual histology
IVUS study conﬁrmed that IVUS-detected attenuated pla-
ques were associated with a large amount of necrotic core
(24). An optical coherence tomography study reported that
IVUS-detected attenuated plaques included unstable lesion
morphologies, such as thin-cap ﬁbroatheroma, lipidic
plaque, plaque rupture, and intracoronary thrombus (25).
Furthermore, recent IVUS studies demonstrated that
attenuated plaque has a high risk of distal embolization,Table 4. Magnetic Resonance Imaging Findings
MVO Group
(n ¼ 23)
No-MVO Group
(n ¼ 45) p Value
LV ejection fraction, % 44.9 (32.2–52.5) 48.3 (42.3–55.1) 0.226
LV end-diastolic volume, ml 123.5 (94.6–145.0) 116.5 (91.4–127.6) 0.276
LV end-systolic volume, ml 62.5 (49.7–84.4) 56.5 (40.7–71.5) 0.120
Infarct size, % 20.0 (13.0–25.0) 13.5 (7.5–20.0) 0.039
Values are median (interquartile range).
LV ¼ left ventricular; MVO ¼ microvascular obstruction.
Shiono et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 8 , 2 0 1 3
Attenuated Plaque and Microvascular Obstruction A U G U S T 2 0 1 3 : 8 4 7 – 5 3
852no-reﬂow phenomenon, and CK-MB elevation after PCI
(14,15,26). Endo et al. (14) reported that attenuated plaque
with a longitudinal length >5 mm was a predictor of no-
reﬂow phenomenon. Subsequently, Wu et al. (15) reported
the circumferential extent of the attenuated plaque was
strongly correlated with no-reﬂow. In the present study, we
also found that not only the presence of ultrasound atten-
uation but also its longitudinal and circumferential size were
associated with MRI-derived MVO.
MVO is associated with worse clinical outcomes in
patients with AMI (3). Rubenstein et al. (27) showed that
MVO predicted greater myocardial damage and worse LV
function after AMI. Nijveldt et al. (19) revealed that MVO
was related to adverse LV remodeling and lack of functional
improvement (19). deWaha et al. (3) found that MVO was
an independent predictor of major adverse cardiac events
in STEMI patients (hazard ratio: 4.23, 95% conﬁdence
interval: 1.73 to 10.34). The present study demonstrated
that IVUS-detected attenuated plaque was a signiﬁcant
predictor of MRI-detected MVO, and the absence of
attenuated plaque at the culprit lesion could indicate the
absence of MVO by MRI. Thus, IVUS might be a useful
tool for risk stratiﬁcation in STEMI patients undergoing
primary PCI.
We demonstrated that patients with IVUS-derived
attenuated plaques were at high risk of MVO after primary
PCI. Once MVO occurs, there is no effective treatment to
improve it. Therefore, the prevention of MVO might be
clinically important. Some possible therapeutic strategies to
prevent distal embolization by using a distal protection
device or pharmacological agents have been suggested
(18,21). Although their effectiveness is inconsistent
(18,21,28), it is possible because they have been applied
indiscriminately to all patients. Their use in selected patients
at high risk of distal embolization may effectively prevent
MVO. If this assumption is proved to be true, a new PCI
strategy using IVUS for STEMI patients could be
established.
Attenuated plaque is often observed at the culprit lesion in
ACS and considered as an IVUS characteristic of vulnerable
plaque. On the other hand, they are sometimes identiﬁed at
nonculprit lesions and have a stable clinical course (29). This
means that ACS are generally caused by vulnerable plaques,
but vulnerable plaques do not necessarily lead to ACS.
Hence, we may happen to see attenuated plaque when we
perform PCI for non-ACS patients. Although we suggested
that the attenuated plaques were associated with the occur-
rence of MVO in STEMI patients, it is unclear whether we
can apply our result to non-ACS patients. Because the
condition of the myocardium is quite different in STEMI
and non-ACS patients due to myocardial edema, endothelial
swelling, and microvascular spasm, the impact of distal
embolization on the occurrence of MVO must be different.
Moreover, the components of attenuated plaque and thelikelihood of distal embolization may be different between
STEMI and non-ACS patients. Further study is needed on
whether attenuated plaque is also associated with MVO in
non-ACS patients.
Study limitations. First, MRI was not performed before
PCI. There is a possibility that some patients may have
MVO before PCI. Second, the passage of a guidewire,
thrombus aspiration device, and IVUS catheter might have
the potential to cause distal embolization and MVO before
balloon dilation and stent deployment. Third, ultrasound
attenuation precludes identifying the vessel border. We
interpolated the EEM area in the plaque with attenuation
(6). Fourth, we used 40-MHz IVUS transducers according
to most previous studies of attenuated plaques. Our results
may not be applicable to the IVUS images acquired by other
frequency transducers because the IVUS frequency can affect
the degrees of signal penetration (e.g., 20-MHz transducers
used in virtual histology IVUS have greater penetration than
40-MHz transducers). Finally, this study was conducted at
a single center with a small sample, and we had a limited
number of MVOs. The relatively small number of observed
events may raise concern about possible overﬁtting of our
multivariate model. Consequently, further study with a large
population would be necessary to clarify the relationship
between attenuated plaque and MVO.
Conclusions
Attenuated plaque with a maximum attenuation angle
>180 and an attenuation length >5 mm was associated
with the occurrence of MVO after primary PCI. IVUS
might to be a useful tool for risk stratiﬁcation in STEMI
patients undergoing primary PCI.
Reprint requests and correspondence: Dr. Takashi Kubo,
Department of Cardiovascular Medicine, Wakayama Medical
University, 811-1, Kimiidera, Wakayama 641-8510, Japan. E-mail:
takakubo@wakayama-med.ac.jp.
REFERENCES
1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intra-
venous thrombolytic therapy for acute myocardial infarction: a quanti-
tative review of 23 randomised trials. Lancet 2003;361:13–20.
2. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no-
reﬂow’ phenomenon: a predictor of complications and left ventricular
remodeling in perfused anterior wall infarction. Circulation 1996;93:
223–8.
3. deWaha S, Desch S, Eitel I, et al. Impact of early vs. late microvascular
obstruction assessed by magnetic resonance imaging on long-term
outcome after ST-elevation myocardial infarction: a comparison with
traditional prognostic markers. Eur Heart J 2010;31:2660–8.
4. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed
contrast enhancement to irreversible injury, infarct age, and contractile
function. Circulation 1999;100:1992–2002.
5. Rochitte CE, Lima JAC, Bluemke DA, et al. Magnitude and time
course of microvascular obstruction and tissue injury after acute
myocardial infarction. Circulation 1998;98:1006–14.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 8 , 2 0 1 3 Shiono et al.
A U G U S T 2 0 1 3 : 8 4 7 – 5 3 Attenuated Plaque and Microvascular Obstruction
8536. Lee SY, Mintz GS, Kim SY, et al. Attenuated plaque detected by
intravascular ultrasound: clinical, angiographic, and morphologic
features and post-percutaneous coronary intervention complication in
patients with acute coronary syndromes. J Am Coll Cardiol Intv 2009;2:
65–72.
7. Okura H, Taguchi H, Kubo T, et al. Atherosclerotic plaque with
ultrasonic attenuation affects coronary reﬂow and infarct size in patients
with acute coronary syndrome: an intravascular ultrasound study. Circ J
2007;71:648–53.
8. Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy
with abciximab reduces angiographically evident thrombus in acute
myocardial infarction: a TIMI 14 substudy. Circulation 2001;103:
2550–4.
9. The TIMI IIIB Investigators. Effects of tissue plasminogen activator
and a comparison of early invasive and conservative strategies in unstable
angina and non-Q-wave myocardial infarction. Results of the TIMI
IIIB trial. Thrombolysis in Myocardial Ischemia. Circulation 1994;89:
1545–56.
10. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral
channel ﬁlling immediately after controlled coronary artery occlusion by
an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:
587–92.
11. Henriques JP, Zijlstra F, van’t Hof AW, et al. Angiographic assessment
of reperfusion in acute myocardial infarction by myocardial blush grade.
Circulation 2003;107:2115–9.
12. Tanaka A, Kawarabayashi T, Nishibori Y, et al. No-reﬂow phenom-
enon and lesion morphology in patients with acute myocardial infarc-
tion. Circulation 2002;105:2148–52.
13. Mintz GS, Nissen SE, Anderson WD, et al. American College of
Cardiology Clinical Expert Consensus Document on Standards for
Acquisition, Measurement and Reporting of Intravascular Ultrasound
Studies (IVUS). A report of the American College of Cardiology Task
Force on Clinical Expert Consensus Documents. J Am Coll Cardiol
2001;37:1478–92.
14. Endo M, Hibi K, Shimizu T, et al. Impact of ultrasound attenuation
and plaque rupture as detected by intravascular ultrasound on the
incidence of no-reﬂow phenomenon after percutaneous coronary
intervention in ST-segment elevation myocardial infarction. J Am Coll
Cardiol Intv 2010;3:540–9.
15. Wu X, Mintz GS, Xu K, et al. The relationship between attenuated
plaque identiﬁed by intravascular ultrasound and no-reﬂow after
stenting in acute myocardial infarction: the HORIZONS-AMI
(Harmonizing Outcomes With Revascularization and Stents in Acute
Myocardial Infarction) trial. J Am Coll Cardiol Intv 2011;4:495–502.
16. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of
myocardial contrast enhancement in fast magnetic resonance images of
2-day-old reperfused canine infarcts. Circulation 1995;92:1902–10.
17. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial
infarction regarding cardiac structure and function and their prognosticsigniﬁcance as assessed by magnetic resonance imaging. Eur Heart J
2005;26:549–57.
18. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reﬂow in
humans. J Am Coll Cardiol 2009;54:281–92.
19. Nijveldt R, Beek AM, Hirsch A, et al. Functional recovery after acute
myocardial infarction: comparison between angiography, electrocardi-
ography, and cardiovascular magnetic resonance measures of microvas-
cular injury. J Am Coll Cardiol 2008;52:181–9.
20. Schwartz RS. Microvascular obstruction in acute coronary syndromes:
onward to a new therapeutic target. Catheter Cardiovasc Intv 2005;66:
170–2.
21. Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular
obstruction and the no-reﬂow phenomenon after percutaneous coronary
intervention. Circulation 2008;117:3152–6.
22. Yamada R, Okura H, Kume T, et al. Histological characteristics of
plaque with ultrasonic attenuation: a comparison between intravascular
ultrasound and histology. J Cardiol 2007;50:223–8.
23. Jinzaki M, Okabe T, Endo A, et al. Detection of attenuated plaque in
stable angina with 64-Multidetector computed tomography. Circ J
2012;76:1182–9.
24. Wu X, Maehara A, Mintz GS, et al. Virtual histology intravascular
ultrasound analysis of non-culprit attenuated plaques detected by
grayscale intravascular ultrasound in patients with acute coronary
syndromes. Am J Cardiol 2010;105:48–53.
25. Kubo T, Matsuo Y, Ino Y, et al. Optical coherence tomography analysis
of attenuated plaques detected by intravascular ultrasound in patients
with acute coronary syndromes. Cardiol Res Pract 2011;2011:687515.
26. Lee T, Kakuta T, Yonetsu T, et al. Assessment of echo-attenuated
plaque by optical coherence tomography and its impact on post-
procedural creatine kinase-myocardial band elevation in elective stent
implantation. J Am Coll Cardiol Intv 2011;4:483–91.
27. Rubenstein JC, Ortiz JT, Wu E, et al. The use of periinfarct contrast-
enhanced cardiac magnetic resonance imaging for the prediction of late
postmyocardial infarction ventricular dysfunction. Am Heart J 2008;
156:498–505.
28. Dangas G, Stone GW, Weinberg MD, et al., EMERALD Investi-
gators. Contemporary outcomes of rescue percutaneous coronary
intervention for acute myocardial infarction: comparison with primary
angioplasty and the role of distal protection devices (EMERALD trial).
Am Heart J 2008;155:1090–6.
29. Bayturan O, Tuzcu EM, Nicholls SJ, et al. Attenuated plaque at
nonculprit lesions in patients enrolled in intravascular ultrasound
atherosclerosis progression trials. J Am Coll Cardiol Intv 2009;2:672–8.KeyWords: attenuated plaque - intravascular ultrasound -
magnetic resonance imaging - microvascular obstruction -
ST-segment elevation myocardial infarction.
